PepVault
/ database / Neurotrophic Peptide Mix

Cerebrolysin

Clinical-grade neurotrophic peptide cocktail used in stroke and dementia.

Evidence
established
Legal status
approved some regions
Half-life
Variable (multi-component)
Routes
im · subq
View on Limitless LifeAdd to compare
What it is

Cerebrolysin is approved in many European, Asian and Latin American countries for ischemic stroke and Alzheimer's. The CARS trials showed functional improvement at 90 days post-stroke.

Mechanism

Porcine brain-derived neuropeptide complex with neurotrophic and neuroprotective effects.

Outcomes it's matched to
Safety

Excellent long-term safety record.

  • Status epilepticus
Legal context

Approved in 50+ countries; not FDA-approved.

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault